Universal Time: 18:18  |  Local Time: 18:18 (0h GMT)
Select your timezone:



Room: E-Poster Hall

P-11.53 Cytomegaloviurs-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient: A case report

Eun Ji Choi, Korea

Department of General Surgery
Ajou University School of Medicine


CMV-associated hemophagocytic syndrome accompanied by CMV hepatitis and pneumonia in renal transplant recipient: A case report

Eun Ji Choi1, Jun Bae Bang1.

1Department of Surgery, Ajou University Hospital, Suwon, Korea

Virus-associated hemophagocytic syndrome (HPS) is a rare but life threatening disease in renal transplant recipients that is mostly caused by cytomegalovirus and Epstein-Barr virus. However, to date, no description of CMV-associated hemophagocytic syndrome accompanied by CMV hepatitis and pneumonia exists in renal transplant recipients. Here, we report a 40-year-old male kidney recipient, who presented with epigastric discomfort, fever, and mild dyspnea two months following transplantation. Laboratory findings revealed bicytopenia, hyperferritinemia, elevated hepatic enzymes, elevated serum lactate dehydrogenase, low level of soluble IL2 receptor, and low NK cell activity. Lung HRCT showed bilateral lower lung ground glass opacity with peribronchiolar consolidation and interlobular septal thickening. Liver biopsy disclosed cytomegalovirus inclusions along with lymphocyte infiltration and erythrophagocytosis. The presence of CMV antigen and viral DNA in the recipient’s serum confirmed acute CMV infection. Following ganciclovir antiviral therapy without discontinuation of immunosuppressive therapy, symptoms gradually resolved and laboratory findings were normalized. As far as we know, this is the first case report CMV-associated hemophagocytic syndrome accompanied by CMV hepatitis and pneumonia in a renal transplant recipient.


[1] Ardalan MR, Shoja MM, Tubbs RS, Esmaili H, Keyvani H. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus B19 infection. American Journal of Transplantation 2018;8:1340-1344.
[2] Karras A, Thervet E, Legendre C. Hemophagocytic syndrome in renal transplant recipients: Report of 17 cases and review of literature. Transplantation 2004;77:238-243.
[3] Meyrier A, Anand S, Yabu JM, Melcher ML, Kambham N. Cytomegalovirus in the tranplant kidney: a report of two cases and review of prophylaxis. NDT Plus. 2011;4(5):342-345.
[4] Nanmoku K, Yamamoto T, Jsujita M, Hiramitsu T, Goto N, et al. Virus-associated hemophagocytic syndrome in renal transplant recipients: Report of 2 cases from a single center. Case Reports in Hematology 2015; 2015: 876301.
[5] Nusshag C, Morath C, Zeier M, Weigand MA, Merle U, et al. Hemophagocytic lymphohistiocytosis in an adult kidney tranplnat recipient successfully treated by plasmapheresis. Medicine 2017; 96(50): 9283.
[6] Ponticelli C, Alberighi ODC. Haemophagocytic syndrome--a life-threatening complication of renal transplantation. Nephrology Dialysis Transplantation. 2019;24(9):2623-2627.


There are no comments yet...

WebApp Sponsor

© 2024 TTS 2020